Clinicopathologic heterogeneity in FTDP ‐17 due to MAPT p.P301L mutation, including a patient with globular glial tauopathy

Conclusions: This clinicopathologic study shows inter‐ and intra‐familial clinicopathologic heterogeneity of FTDP‐17 due to MAPT p.P301L mutation, including GGT in one patient.This article is protected by copyright. All rights reserved.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fnan.12367

Source: Neuropathology and Applied Neurobiology - September 30, 2016 Category: Neurology Authors: Pawel Tacik, Monica Sanchez ‐Contreras, Michael DeTure, Melissa E. Murray, Rosa Rademakers, Owen A. Ross, Zbigniew K. Wszolek, Joseph E. Parisi, David S. Knopman, Ronald C. Petersen, Dennis W. Dickson Tags: Original Article Source Type: research